Global Isothermal Nucleic Acid Amplification Technologies Market Report 2013-2017

December 27, 2013

DUBLIN, December 27, 2013 /PRNewswire/ –

Research and Markets (http://www.researchandmarkets.com/research/n7z298/isothermal
) has announced the addition of the “Global Isothermal Nucleic Acid Amplification
Technologies Market Report 2013-2017″
[http://www.researchandmarkets.com/research/n7z298/isothermal ] report to their offering.

http://photos.prnewswire.com/prnh/20130307/600769 )

Isothermal Nucleic Acid Amplification Technologies (INAAT) discloses the promising
trends in Nucleic acid testing and their applications in molecular diagnostics and
laboratory research on a global scale.

The World Health Organization (WHO) proposes that an ideal diagnostic test, that is
suitable for developing countries, should be Affordable, Sensitive, Specific and
User-friendly (simple to perform in a few steps with minimal training), Robust and rapid
(results available in minutes), Equipment free and Deliverable to the end user (ASSURED).
Nucleic acid amplification tests targeting pathogen markers have high sensitivity and
specificity, but generally fail to meet the ASSURED guidelines in terms of affordability,
rapidity, and being equipment free.

However, INAAT has recently attracted the scientific community due to their operation
in single temperature and distinct features by meeting the ASSURED guidelines. With
fine-tunings in the amplification methodology, a variety of INAAT types are discovered
each being independent, driving the diagnostic platform towards Point-Of-Care (POC)
testing at low resource settings.

This research report provides in-depth details about technology evolution, and
innovation trends across the industry, technology investment potential and competitive
market landscape. The analyses ensuing out of this research service may provide, useful
insights for end users, while prioritizing the appropriate choice of modality for nucleic
acid testing in research and diagnostics.

        Key Topics Covered:

        1 Introduction
        1.1 Key Take-Aways
        1.2 Report Scope
        1.3 Research Methodology
        1.4 Key Data Sources

        2 Executive Summary

        3 Isothermal Nucleic Acid Amplification Technologies (INAAT) - Technology Landscape
        3.1 Technology Overview
        3.2 INAAT Vs Conventional Methods - Competitive Advantages
        3.3 Technology Value Chain Analysis
        3.4 Comparative Analysis of INAAT Types
        3.5 Applications
        3.6 Product/Technology Innovations - Applications

        4 Technology Investment Potential
        4.1 Investment Climate Assessment
        4.2 Investment Opportunities

        5 INAAT - Market Landscape Analysis
        5.1 Market Segmentation
        5.2 INAAT Market Share In Molecular Diagnostics (MDX)
        5.3 Global Market Forecast
        5.4 Market Dynamics
        5.5 Demand Side Analysis

        6 INAAT - Technology Adoption Potential & Development By Geography
        6.1 Technology Adoption & Development - Key Findings
        6.2 North America
        6.3 Europe
        6.4 ASIA
        6.5 Rest Of The World
        6.6 Regions With High Technology Adoption

        7 Competitive Landscape
        7.1 Mergers & Acquisitions (2007-2012)
        7.2 Partnerships & Collaborations (2007-2012)
        7.3 New Product Development Initiatives - 2012

        8 Patent Analysis And Research Trend (Publications) 2007-2012
        8.1 Patent Landscape Analysis (2007-2012)
        8.2 Research Landscape (2007-2012)


        10 Analyst Insights & Recommendations
        10.1 Strategic Recommendations For Technology & Business Management
        10.2 Key Invitations & Opportunities

        11 Company Profiles

        12 Appendix

        13 Glossary

Companies Mentioned:

        - Becton, Dickinson And Company (Bd)
        - Biohelix
        - Biomerieux
        - Eiken Chemical Co., Ltd.
        - Hologic Gen-Probe
        - Lucigen
        - Meridian Bioscience Inc
        - New England Biolabs
        - Novartis Diagnostics
        - Nugen
        - Qiagen
        - Twistdx
        - Ustar Biotechnologies (Hangzhou) Ltd.

For more information visit


Media Contact: Laura Wood, +353-1-481-1716, press@researchandmarkets.net



SOURCE Research and Markets

Source: PR Newswire

comments powered by Disqus